372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager - Victoria Smith; Patrick Chun; Alexander Starodub; Sarina Piha-Paul; Raghad Karim; Michael Shafique; Gabriel Tinoco Suarez; Curtis Ruegg (Journal for ImmunoTherapy of Cancer, 2020)